Growth Metrics

Halozyme Therapeutics (HALO) Prepaid Assets: 2010-2025

Historic Prepaid Assets for Halozyme Therapeutics (HALO) over the last 15 years, with Sep 2025 value amounting to $150.7 million.

  • Halozyme Therapeutics' Prepaid Assets rose 21.82% to $150.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $150.7 million, marking a year-over-year increase of 21.82%. This contributed to the annual value of $119.5 million for FY2024, which is 79.96% up from last year.
  • According to the latest figures from Q3 2025, Halozyme Therapeutics' Prepaid Assets is $150.7 million, which was up 13.25% from $133.0 million recorded in Q2 2025.
  • Halozyme Therapeutics' 5-year Prepaid Assets high stood at $150.7 million for Q3 2025, and its period low was $44.7 million during Q1 2021.
  • Moreover, its 3-year median value for Prepaid Assets was $100.2 million (2025), whereas its average is $95.4 million.
  • As far as peak fluctuations go, Halozyme Therapeutics' Prepaid Assets decreased by 20.29% in 2023, and later surged by 85.30% in 2024.
  • Halozyme Therapeutics' Prepaid Assets (Quarterly) stood at $53.9 million in 2021, then skyrocketed by 32.34% to $71.3 million in 2022, then declined by 6.86% to $66.4 million in 2023, then skyrocketed by 79.96% to $119.5 million in 2024, then climbed by 21.82% to $150.7 million in 2025.
  • Its Prepaid Assets stands at $150.7 million for Q3 2025, versus $133.0 million for Q2 2025 and $100.2 million for Q1 2025.